CB issuance terms amended, dilution 15.70%
애드바이오텍
179530
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2589
Risk-adjusted indicator based on 2589 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • New CB Issuance Amount: 10,000,000,000 KRW
- • New Conversion Price: 1,992 KRW/Share
- • New Convertible Shares: 5,020,080 Shares
- • Dilution Rate (New CB only): 15.70%
- • Total Potential Dilution (incl. existing CBs): 41.52%
AI Analysis Summary
ADBIOTECH Co.,Ltd. has amended its Material Fact Report regarding the issuance of Convertible Bonds (CBs). The key changes include a revised payment date to August 19, 2026, and a new conversion price of 1,992 KRW per share, down from 2,264 KRW. This new CB issuance of 10 billion KRW could lead to the issuance of 5,020,080 shares, representing a 15.70% dilution of current outstanding shares. Including previously issued and outstanding CBs, the total potential dilution stands at 41.52%. The funds are for operational needs. The increased dilution and lower conversion price are negative for existing shareholders.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.